Servicio de Cardiología

Nov 25, 2024 | academic.oup.com | Servicio de Cardiología |del Val

Drug-coated balloons (DCB) offer an appealing therapeutic alternative for the treatment of patients with coronary in-stent restenosis (ISR). In-segment late lumen loss, translating into recurrent ISR and the clinical need for target lesion revascularization represent a well-established and thoroughly investigated limitation of DCB in this setting.

Aug 17, 2024 | elsevier.es | Cotobal Rodeles |Facultad de Medicina |Universidad Complutense |Servicio de Cardiología

ResumenObjetivoConocer las opiniones de los nuevos médicos internos residentes (MIR) sobre Medicina Familiar y Comunitaria (MFyC) y temas profesionales y personales. MétodosEncuesta anónima a 837 nuevos MIR de la comunidad de Madrid. ResultadosLa edad media fue de 25,6±3,5 años, 525 (62,7%) cursaron la asignatura teórica de MFyC, 799 (95,5%) realizaron prácticas en Atención Primaria durante la carrera y 606 (72,4%) considera relevante rotar en MFyC.

May 13, 2024 | onlinelibrary.wiley.com | Carlos Diaz-Arocutipa |Guillermo Moreno |Servicio de Cardiología |Facultad de Enfermería |Facultad de enfermería

AHRQ Agency for Healthcare Research and Quality CI confidence interval HFRS Hospital Frailty Risk Score ICD-10 International Classification of Disease, Tenth Revision IE infective endocarditis IPTW inverse probability of treatment weighting NIS National Inpatient Sample OR odds ratio SMD standardized mean difference 1 INTRODUCTION Infective endocarditis (IE) is a disease associated with high mortality.1 In recent decades, the epidemiology of IE has changed, with increasing patient age and...

Apr 2, 2024 | academic.oup.com | Outcomes Research |Servicio de Cardiología |Santiago de Compostela

The retrospective NEPTUNO study evaluated the effectiveness of the CNIC-polypill (including acetylsalicylic acid, ramipril, and atorvastatin) vs other therapeutic approaches in secondary prevention for cardiovascular (CV) disease. In this substudy, the focus was on the subgroup of patients with ischaemic heart disease (IHD). Patients on four strategies: CNIC-polypill, its monocomponents as loose medications, equipotent medications, and other therapies.